Unknown

Dataset Information

0

MTNR1B Gene Polymorphisms Are Associated With the Therapeutic Responses to Repaglinide in Chinese Patients With Type 2 Diabetes Mellitus.


ABSTRACT: The objective of this study was to investigate whether MTNR1B gene variants influence repaglinide response in Chinese patients with newly diagnosed type 2 diabetes mellitus (T2DM). A total of 300 patients with T2DM and 200 control subjects were enrolled to identify MTNR1B rs10830963 and rs1387153 genotypes by real-time polymerase chain reaction (PCR), with subsequent high-resolution melting (HRM) analysis. Ninety-five patients with newly diagnosed T2DM were randomly selected to undergo 8 weeks of repaglinide treatment (3 mg/day). After 8-week repaglinide monotherapy, patients with at least one G allele of MTNR1B rs10830963 showed a smaller decrease in fasting plasma glucose (FPG) (P = 0.031) and a smaller increase in homeostasis model assessment for beta cell function (HOMA-B) (P = 0.002) levels than those with the CC genotype did. The T allele carriers at rs1387153 exhibited a smaller decrease in FPG (P = 0.007) and smaller increases in postprandial serum insulin (PINS) (P = 0.016) and HOMA-B (P < 0.001) levels compared to individuals with the CC genotype. These data suggest that the MTNR1B rs10830963 and rs1387153 polymorphisms are associated with repaglinide monotherapy efficacy in Chinese patients with T2DM.

SUBMITTER: Wang T 

PROVIDER: S-EPMC6855210 | biostudies-literature | 2019

REPOSITORIES: biostudies-literature

altmetric image

Publications

<i>MTNR1B</i> Gene Polymorphisms Are Associated With the Therapeutic Responses to Repaglinide in Chinese Patients With Type 2 Diabetes Mellitus.

Wang Tao T   Wang Xiao-Tong XT   Lai Ran R   Ling Hong-Wei HW   Zhang Fan F   Lu Qian Q   Lv Dong-Mei DM   Yin Xiao-Xing XX  

Frontiers in pharmacology 20191107


The objective of this study was to investigate whether <i>MTNR1B</i> gene variants influence repaglinide response in Chinese patients with newly diagnosed type 2 diabetes mellitus (T2DM). A total of 300 patients with T2DM and 200 control subjects were enrolled to identify <i>MTNR1B</i> rs10830963 and rs1387153 genotypes by real-time polymerase chain reaction (PCR), with subsequent high-resolution melting (HRM) analysis. Ninety-five patients with newly diagnosed T2DM were randomly selected to und  ...[more]

Similar Datasets

| S-EPMC6746626 | biostudies-literature
| S-EPMC5114551 | biostudies-literature
| S-EPMC5244830 | biostudies-literature
| S-EPMC5220536 | biostudies-literature
| S-EPMC4808923 | biostudies-literature
| S-EPMC6489531 | biostudies-literature
| S-EPMC4002970 | biostudies-literature
| S-EPMC2860533 | biostudies-literature
| S-EPMC2597741 | biostudies-literature
| S-EPMC4964615 | biostudies-literature